A markedly increased expression of tTG in the mucosa, is found in patients suffering from coeliac disease. Anti-tTG autoantibodies of both IgA and IgG classes originate from B lymphocytes in the intestinal mucosa of CD patients, with IgA anti-tTG considered to be highly specific as a clinical marker for CD.
This product has been designed to provide very high purity (>90%) with excellent assay reactivity when tested against other commercially available tTG recombinants. As with all AROTEC products, our recombinant tTG is fully manufactured in our ISO accredited facility in Wellington, New Zealand, providing you with another high-quality reagent for the autoimmune diagnostic market. Please contact your local representative for further information or email us directly at info@arodia.com. |
|